AbbVie Inc. (ETR:4AB)
158.40
+3.60 (2.33%)
Apr 24, 2025, 5:35 PM CET
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
€989,327
Profits / Employee
€74,427
Market Cap
275.52B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Merck KGaA | 59,020 |
Siemens Healthineers AG | 72,000 |
Fresenius SE & Co. KGaA | 176,486 |
Bayer Aktiengesellschaft | 90,587 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 23,412 |
AbbVie News
- 3 hours ago - A Glimpse of AbbVie's Earnings Potential - Benzinga
- 4 hours ago - AbbVie submits marketing application to FDA for short term frown lines treatment - Seeking Alpha
- 4 hours ago - Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - ABBV - Accesswire
- 4 hours ago - AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines - PRNewsWire
- 7 hours ago - The Gross Law Firm Reminds Cerevel Therapeutics Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ABBV - PRNewsWire
- 23 hours ago - Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights – ABBV - GlobeNewsWire
- 1 day ago - Salesforce, AbbVie, Intuitive Surgical And An Industrial Stock On CNBC's 'Final Trades' - Benzinga
- 1 day ago - EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain - Benzinga